Johnson, Kari A <br/><br/>
The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.  [electronic resource] 

 -  Neuropharmacology  Mar 2013 
 - 187-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2012.03.029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminobutyrates--administration & dosage<br/>Animals<br/>Benzoates--administration & dosage<br/>Catalepsy--chemically induced<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Dopamine D2 Receptor Antagonists<br/>Dose-Response Relationship, Drug<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Excitatory Amino Acid Agonists--administration & dosage<br/>Forelimb--drug effects<br/>Glycine--administration & dosage<br/>Haloperidol<br/>Injections, Intraventricular<br/>Male<br/>Neostriatum--drug effects<br/>Parkinsonian Disorders--drug therapy<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D2--metabolism<br/>Receptors, Metabotropic Glutamate--agonists<br/>Reserpine<br/>Time Factors